Sprachauswahl: DE |
EN
Referenten
Wie immer auf dem Pharma-Kongress diskutieren Sie die aktuellen Trends und Herausforderungen mit Referenten aus den führenden europäischen Pharma-Unternehmen, aus Behörden sowie von Universitäten.
Referenten des Pharma-Kongresses 2019:
- Ib Alstrup, Danish Medicines Agency
Medicines Inspector. - Gabriel Anderson, Novartis
Co-lead Novartis's visual inspection expert Network. - Dr. Abdulaziz Awad, Saudi Biotechnology Manufacturing Company
Board Member and CEO. - Eva-Maria Baumgartner, Syntacoll
Validation Manager. - Dr. Matthias Beck, Oncotec
Manager New Business Development. - Stefan Bieler, IDT-Biologika
Process engineer at IDT-Biologika, Department Filling and Freeze Drying Vaccines. - Maximilian Bischl, Roche Diagnostics
Manager Operations. - Dr. Clemens Borkenstein, ZETA Biopharma
Head of Department Quality Assurance and Qualification. - Dr. Berthold Düthorn, Robert Bosch Packaging Technology
Vice President. - Zinaid Dzinovic, Novartis
Program Manager MES. - Klaus Eichmüller, Wolnzach, c/o Regional Council Darmstadt, GMP Inspectorate, Germany
Head of Inspectorate. - Dr. Detlef Eisenkraetzer, Roche Diagnostics
Director Fermentation Development. - Sandrine Favre, Octapharma
Head of Corporate Pharmaceutical Production. - Klaus Feuerhelm, Regierungspräsidium Tübingen
GMP-Inspektor. - Dr. Andreas Grummel, Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM)
Apotheker, Wissenschaftlicher Direktor und Mitglied der BfArM PAT Gruppe. - Dr. Friedrich Haefele, Boehringer Ingelheim Pharma
Head of the department Biopharma Fill & Finish Germany. - Dr. Martin Haerer, Rommelag CMO
Responsible for Business Development, Technology Transfer and Research and Development and acting as QP. - Thomas Hahlgans, CSL Behring
Leiter Instandhaltungsmanagement. - Uwe Harenberg, GESA
- Managing Director.
- Dr. Philip Hörsch, Vetter Pharma Fertigung
Director QA - Validation/Risk Management/Trending. - Dr. Thilo Kaltenbach, Roland Berger (Pharma & Healthcare Competence Center)
Senior Partner. - Dr. Matthias Kahl, Wilco
Head of Development and Lab Service. - Kieran Keaney, Abbvie Ireland
Senior Engineer. - Alan Kelly, Genzyme
Mechanical engineer in the technical development department. - Dr. Gerald Kindermann, F. Hoffmann La-Roche
QA and GMP Compliance Lead. - Peter Koop, Arvato Systems
Vice President. - Dr. Johannes Krämer, CSL Behring
Leiter des Engineerings. - Felix Krumbein, Roche Diagnostics
Head of Inspections-Systems-Support. - Dr. Jean-Denis Mallet, ECA
Former head of the French Inspection Department AFSSAPS. - Dr. Thomas Meindl, Labor LS
Division Manager. - Didier Meyer, DMCompliance
Consultant at DMCompliance. - Gerd Moelgaard, ECA Validation Interest Group
Consultant, Moelgaard Consuliting. - Christian Mrotzek, Fresenius Kabi
Senior Director Engineering and Technology. - Dr. Daniel Müller, Local Authority of Baden Württemberg
Head of GMP Inspectorate. - Dr. Felix Oehme, Bayer
Head of Biological Development. - Thomas Page, FUJIFILM Diosynth Biotechnologies
Vice President, Engineering & Asset Development. - Thomas Reiner, Berndt+Partner
CEO; Vorstandsmitglied der World Packaging Organisation. - Armin Rockenschaub, GE Healthcare
Manufacturing Engineering and Quality Engineering Leader. - Doris Rottenbusch, Vetter Pharma-Fertigung
Leading a team of experts in Development Service - Technology & Process Transfer. - Knud Ryhl, Novo Nordisk
Senior Lead Auditor / Senior Specialist. - Prof. Farshid Sadeghipour, Lausanne University Hospital
Head of Pharmacy. - Yves Samson, ECA Data Integrity & IT Compliance Interest Group
Kereon AG, CEO & e-Compliance SME. - Dr. Ralph Sapper, Merck
Senior Projektmanager. - Matthias Schaar, Novartis Pharma, Stein
Teamleader Qualification & Infrastructure in Microbiological Department. - Gabriela Schallmeiner, Austrian QP Association
Deputy Chair. - Dr. Ute Schleyer, Vetter Pharma Fertigung
Project Manager, Site & Plant Development. - Thorsten Schlosser, Allergopharma
Vice President Technical Operations. - Stefan Schoettle, Roche Diagnostics
Head of Informatics Pharma Manufacturing Mannheim. - Dr. Andreas Schreiner, Novartis
Leiter Validierung. - Dr. Thomas Schwarz, Novartis
Leiter Strategische Planung. - Christof Specht, F. Hoffmann La-Roche
Gesamtprojektleiter & Bauherr. - Dr. Clemens Stief, Pfizer
Teamleiter Produkt- und Prozess-Entwicklung. - Dr. Frank Stieneker, Consultant und QP
Produktentwicklung, Prozess- und Anlagendesign-Funktion. - Christian Sturm, Sanofi
Change Leader Site Frankfurt Biotechnology. - Dr. Arno Terhechte, Bezirksregierung Münster
Medicines Inspector. - Dr. Frank Thielmann, Novartis
Operation Excellence Leader Biologics. - Patrick Vanhecke, GSK Vaccines
Expert in Isolator and Aseptic Filling Technologies and Room decontamination process. - Martin Wenzel, Roche Diagnostics
Gruppenleiter Technik, Clinical Supply Center.